Peter Kaiser, Chief Development Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 2,967 shares at $8.20 ($24K) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Open-market sale of $24k OCUL by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-02-25 | $23K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $36K | — | Filing → |
| OCUL | SELL | 2025-10-06 | $213K | — | Filing → |